UChicago Medicine Jonas Center Cellular Therapy Symposium

 

UChicago Medicine Jonas Center Cellular Therapy Symposium
L

Ex Vivo PI3K Inhibition Enhances CAR T-Cell Therapy for DLBCL

By UChicago Medicine Jonas Center Cellular Therapy Symposium FEATURING Lishi Xie
By UChicago Medicine Jonas Center Cellular Therapy Symposium FEATURING Lishi Xie
16 views
October 19, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
2023
22:02

Immune Special Forces: T-Cell IO for Combating Viral Infections

UChicago Medicine Jonas Center Cellular Therapy Symposium

M. Keller

15 views
20:08

Engineering Tregs Against Anti-Drug Antibody Formation

UChicago Medicine Jonas Center Cellular Therapy Symposium

M. Biswas

29 views
27:15

Challenges With CAR T-Cell Therapy for Multiple Myeloma

UChicago Medicine Jonas Center Cellular Therapy Symposium

S. Parekh

186 views
11:16

Targeting PRDM1 to Enhance CAR T-Cell Efficacy Against DLBCL

UChicago Medicine Jonas Center Cellular Therapy Symposium

S. Wang

23 views
08:28

Ex Vivo PI3K Inhibition Enhances CAR T-Cell Therapy for DLBCL

UChicago Medicine Jonas Center Cellular Therapy Symposium

L. Xie

16 views